MeiraGTx Holdings MGTX
NASDAQ MGTX
$13.89 -0.08 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

MeiraGTx Holdings (MGTX) Enterprise Value (2018 - 2026)

MeiraGTx Holdings' (MGTX) quarterly Enterprise Value came in at -$65.9 million in Q4 2025, up 36.4% YoY from -$48.3 million in Q4 2024, and down 344.25% on a QoQ basis from -$14.8 million in Q3 2025.

Analysis

MeiraGTx Holdings (MGTX) Enterprise Value (2018 - 2026) Analysis & Trends

MeiraGTx Holdings (MGTX) has 9 years of Enterprise Value data on file, last reported at -$65.9 million in Q4 2025.

  • Quarterly Enterprise Value rose 36.4% year-over-year to -$65.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$65.9 million (up 36.4% YoY) and the FY2025 annual result came in at -$65.9 million, up 36.4% from the prior year.
  • Enterprise Value fell to -$65.9 million in Q4 2025, from -$14.8 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$14.8 million in Q3 2025 to a low of -$199.4 million in Q1 2021.
  • A 5-year average of -$102.8 million and a median of -$108.7 million in 2022 frame the typical range for Enterprise Value.
  • Annual changes were most pronounced in 2024 — Enterprise Value sank 94.14% — and 2025, when it soared 88.13%.
  • Tracing MGTX's Enterprise Value over 5 years: stood at -$137.7 million in 2021, then climbed by 16.11% to -$115.5 million in 2022, then dropped by 13.1% to -$130.6 million in 2023, then climbed by 20.66% to -$103.7 million in 2024, then jumped by 36.4% to -$65.9 million in 2025.
  • The last three Enterprise Value figures came in at -$65.9 million (Q4 2025), -$14.8 million (Q3 2025), and -$32.2 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 MeiraGTx Holdings 1.27 Bn 1.13 Bn 315.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.13 Bn
Dec 31, 2025 578.98 Mn
Sep 30, 2025 647.51 Mn
Jun 30, 2025 492.34 Mn
Mar 31, 2025 471.93 Mn
Dec 31, 2024 373.78 Mn
Sep 30, 2024 198.96 Mn
Jun 30, 2024 171.30 Mn
Mar 31, 2024 270.03 Mn
Dec 31, 2023 315.83 Mn
Sep 30, 2023 228.22 Mn
Jun 30, 2023 307.30 Mn
Mar 31, 2023 181.84 Mn
Dec 31, 2022 200.56 Mn
Sep 30, 2022 261.31 Mn
Jun 30, 2022 266.35 Mn
Mar 31, 2022 505.46 Mn
Dec 31, 2021 919.89 Mn
Sep 30, 2021 440.46 Mn
Jun 30, 2021 514.24 Mn